• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症患者血浆糖苷酶和蛋白酶活性增加:可能在慢性肾衰竭贫血病因学中起作用。

Increased plasma glycosidase and protease activity in uraemia: possible role in the aetiology of the anaemia of chronic renal failure.

作者信息

Shannon J S, Lappin T R, Elder G E, Roberts G M, McGeown M G, Bridges J M

出版信息

Clin Chim Acta. 1985 Dec 31;153(3):203-7. doi: 10.1016/0009-8981(85)90353-5.

DOI:10.1016/0009-8981(85)90353-5
PMID:3907890
Abstract

We have measured plasma N-acetyl-beta-D-glucosaminidase (EC 3.2.1.30) and neuraminidase (EC 3.2.1.18) activities as markers of glycosidase activity and immunoreactive trypsin (EC 3.4.21.4) levels as a marker of proteolytic potential in the plasma of normal and uraemic subjects. The levels of all of these enzymes are significantly elevated in the plasma of uraemic subjects when compared to normal. We have postulated that the combined attack of glycosidases and proteases on erythropoietin will lead to fragmentation of this glycoprotein hormone with loss of activity. This may be a major contributory cause to the anaemia of chronic renal failure.

摘要

我们已测定正常人和尿毒症患者血浆中N-乙酰-β-D-氨基葡萄糖苷酶(EC 3.2.1.30)和神经氨酸酶(EC 3.2.1.18)的活性作为糖苷酶活性的标志物,以及免疫反应性胰蛋白酶(EC 3.4.21.4)水平作为血浆中蛋白水解潜能的标志物。与正常人相比,尿毒症患者血浆中所有这些酶的水平均显著升高。我们推测糖苷酶和蛋白酶对促红细胞生成素的联合攻击将导致这种糖蛋白激素的片段化并丧失活性。这可能是慢性肾衰竭贫血的一个主要促成原因。

相似文献

1
Increased plasma glycosidase and protease activity in uraemia: possible role in the aetiology of the anaemia of chronic renal failure.尿毒症患者血浆糖苷酶和蛋白酶活性增加:可能在慢性肾衰竭贫血病因学中起作用。
Clin Chim Acta. 1985 Dec 31;153(3):203-7. doi: 10.1016/0009-8981(85)90353-5.
2
Neuraminidase-like activity in sera of uremic anemic patients.
Nephron. 1984;37(1):35-8. doi: 10.1159/000183204.
3
The anaemia of chronic renal failure: a potentially treatable catabolic phenomenon?慢性肾衰竭贫血:一种潜在可治疗的分解代谢现象?
Med Hypotheses. 1986 May;20(1):29-36. doi: 10.1016/0306-9877(86)90083-6.
4
Decreased plasma glutathione peroxidase activity in uraemic patients.尿毒症患者血浆谷胱甘肽过氧化物酶活性降低。
Nephron. 2000 Mar;84(3):278-81. doi: 10.1159/000045591.
5
[Lysosomal leukocyte glycosidases in childhood bronchial asthma].
Vopr Med Khim. 1991 Sep-Oct;37(5):35-8.
6
Porphobilinogen and porphyrin synthesis in reticulocytes from uraemic patients.
Proc Eur Dial Transplant Assoc. 1975;11:383-90.
7
The anaemia of chronic renal failure in sheep: studies in vitro.
Br J Haematol. 1984 Nov;58(3):491-500. doi: 10.1111/j.1365-2141.1984.tb03996.x.
8
Association between serum cholesterol and leucocyte lysosomal function.
Ann Clin Biochem. 1994 Jan;31 ( Pt 1):91-3. doi: 10.1177/000456329403100117.
9
Plasma-immunoreactive trypsin in chronic renal failure.慢性肾衰竭中的血浆免疫反应性胰蛋白酶
Digestion. 1980;20(5):334-5. doi: 10.1159/000198456.
10
Peliosis of the spleen: possible association with chronic renal failure and erythropoietin therapy.脾脏紫癜症:可能与慢性肾衰竭及促红细胞生成素治疗有关。
Postgrad Med J. 1995 Aug;71(838):493-6. doi: 10.1136/pgmj.71.838.493.

引用本文的文献

1
A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.在开始透析前 3 个月内,比较聚乙二醇重组人促红素-β与达贝泊汀-α对慢性肾脏病患者维持血红蛋白效果的研究。
Drugs R D. 2017 Sep;17(3):389-396. doi: 10.1007/s40268-017-0188-6.
2
Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.在存在唾液酸代谢酶唾液酸酶的情况下,聚乙二醇化促红细胞生成素β(Epoetin beta pegol)而非重组促红细胞生成素,在体内仍保留其造血作用。
Int J Hematol. 2016 Aug;104(2):182-9. doi: 10.1007/s12185-016-2000-8. Epub 2016 Apr 15.